Micromolecular reversible BTK inhibitor for treating rheumatoid arthritis

作者: Yao Xia , Sun Xiuyun , Rao Yu

DOI:

关键词:

摘要: The invention relates to a micromolecular reversible BTK inhibitor for treating rheumatoid arthritis, and specifically provides compound. compound is the as shown in formula I, or stereisomer, geometrical isomer tautomer thereof, nitric oxide, aquo-complex, solvate, metabolite pharmaceutically acceptable salts prodrugs. inventor finds that polysubstitutedquinolone derivate thereof I can be used high activity during arthritis.

参考文章(3)
John David Lawson, Toufike Kanouni, Young K. Chen, Christopher Smith, Haixia Wang, Mark Sabat, Cinnoline derivatives as as btk inhibitors ,(2013)
Zhang Jiancun, Wang Xiaojun, Zhang Yingjun, Zhou Pingjian, Xiong Shaohui, Yang Chuanwen, Huang Changwei, Cathepsin K inhibitor and application thereof ,(2017)
Fang Qinghong, Luo Ming, Jiang Haigang, Zhang Yingjun, Xie Hongming, Antivirus nucleoside analog prodrug and composition and applications thereof ,(2018)